Search results
Prenatal testing offers a window for finding a mother's cancer risk
Medical Xpress· 2 days agoThe researchers found that such an approach is not only cost-effective, it also can identify at-risk people at a time when cancer screening and other preventative strategies could save their ...
Six cancer treatment breakthroughs pushing us closer to a cure
The Telegraph via Yahoo News· 2 days agoWhat will it treat? NHS England said the drug will be available for post-menopausal women at...
Gene variants foretell the biology of future breast cancers, study finds
Medical Xpress· 3 days agoThe study challenges the dogma that most cancers arise as the result of random mutations that accumulate during our lifetimes. Instead, it points to the active involvement of gene sequences ...
Seven romance novels to heat up your summer
Anchorage Daily News· 4 days agoSummer is almost here, and that means we’re in for days of sticky heat, flushed skin and sweaty palms. Which is also exactly how you should feel after...
Tango Therapeutics shares target cut by H.C. Wainwright, highlights key drug By Investing.com
Investing.com· 5 days agoOn Tuesday, H.C. Wainwright adjusted its financial outlook for Tango Therapeutics Inc. (NASDAQ:TNGX)...
Breast Cancer in Young Women: Rates Rise, Guidelines Shift
WebMD· 4 days agoBreast cancer does not discriminate based on age. Women across the world are increasingly becoming diagnosed with breast cancer under the age of 40. Researchers from the Washington University ...
The -25.66% Simple Moving Average of Tango Therapeutics Inc’s (TNGX) Stock in the Past 200 Days –...
NewsHeater· 2 days agoThe stock of Tango Therapeutics Inc (TNGX) has seen a -9.88% decrease in the past week, with a -13.51% drop in the past month, and a -40.16% decrease in the past quarter. The volatility ratio ...
Breast Cancer Treatment Doesn't Bar Motherhood for Most Women
WebMD· 3 days agoMaggie Louks was diagnosed with breast cancer 12 years ago at the age of 28. Louks’s doctors wanted to treat her cancer aggressively, given the fact she was so young at the time she was diagnosed ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 2 days agoNext-generation-sequencing-based homologous recombination deficiency (HRD) assay based on QIAGEN’s QIAseq xHYB technology, QIAGEN Digital Insight solutions, and Myriad’s proprietary, FDA-approved MyChoice CDx® biomarkers QIAGEN to make kit-based
Qiagen, Myriad Genetics to Develop Sequencing-Based Homologous Recombination Deficiency Kit
GenomeWeb News· 2 days agoQiagen and Myriad Genetics announced on Thursday that they have agreed to develop a globally distributable kit-based test for analyzing homologous recombination deficiency (HRD) status. Under ...
